Access to hepatitis C treatment for patients in drug substitution programmes: the fight is far from over.

Access to hepatitis C treatment for patients in drug substitution programmes: the fight is far from over. Swiss Med Wkly. 2017 Dec 12;147:w14570 Authors: Negro F, Maistat L PMID: 29231233 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/29231233?dopt=Abstract

Source: Swiss Medical Weekly - December 12, 2017 Category: General Medicine Authors: Negro F, Maistat L Tags: Swiss Med Wkly Source Type: research

More News: General Medicine | Hepatitis | Hepatitis C | Switzerland Health